Immunoglobin M Anti-myelin-associated-glycoprotein Peripheral Neuropathy

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Immunoglobin M Anti-myelin-associated-glycoprotein Peripheral Neuropathy trials may be worth asking about

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT03918421

Immunoglobulin M (IgM)-Anti-myelin-associated-glycoprotein(MAG) Peripheral Neuropathy Study

There is no international consensus regarding how to assess and treat patients with immunoglobulin M (IgM)-anti-myelin-associated-glycoprotein (MAG) monoclonal…

France45 participantsStarted 2020-06-23Updated 2026-01-20

Treatment: Clinical examination and patients' questionnaires regarding activity and participation (preliminary Immunogloblin M (IgM)-Rasch-built overall Disability Scale (RODS), and finalized IgM-RODS)

Immunoglobin M Anti-myelin-associated-glycoprotein Peripheral Neuropathy

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Immunoglobulin M (IgM)-Anti-myelin-associated-glycoprotein(MAG) Peripheral Neuropathy Study

All recent trials (1 shown)

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Immunoglobulin M (IgM)-Anti-myelin-associated-glycoprotein(MAG) Peripheral Neuropathy Study

All recent trials (1 shown)